Advanced Solid Tumors: T3P-Y058-739 Treatment

We are testing a new genetically-modified bacterium for patients with advanced solid tumors. This study aims to explore its safety and potential benefits in treating cancer.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Universitari Vall D Hebron
Medical Oncology
Barcelona, Spain
Hospital Universitario La Paz
Medical Oncology Service
Chamartín, Spain
Institut Catala D'oncologia
Medical Oncology Service
L'Hospitalet de Llobregat, Spain

Sponsor: T3 Pharmaceuticals AG
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.